1. Wenzheng Li, Zheng Wu, Hongyu Peng, Donghui Zhao, Ze Zheng, Bing Tian, Shiying Li, Shujuan Cheng, Jinghua Liu*.Predicting the Success Rate of Elective Percutaneous Coronary Intervention for Prior Failed Chronic Total Occlusion: a Novel Scoring System.Journal of Cardiovascular Translational Research.2022.15(4).797-804.SCI |
2. Yuchen Shi, Ze Zheng, Jesse Luo, Yingkai Li, Songyuan He, Xueqian Shen, Jinghua Liu*.Possible effects of fibroblast growth factor 21 on vascular calcification via suppressing activating transcription factor 4 mediated apoptosis and osteogenic transformation in rats.Cell Biochemistry and Function.2022.40(4).349-358.SCI |
3. Tong Liu, Zheng Wu, Jinghua Liu*, Yun Lv, Wenzheng Li.Metabolic syndrome and its components reduce coronary collateralization in chronic total occlusion: An observational study.Cardiovascular Diabetology.2021.20(1).104.SCI |
4. Feng Gan#, Jiafang Huang, Tianran Dai, Maorong Li, Jinghua Liu*.Serum level of fibroblast growth factor 21 predicts long-term prognosis in patients with both diabetes mellitus and coronary artery calcification. .Annals of Palliative Medicine.2020.9(2).368-374.SCI |
5. 马彩云#, 刘祎秀, 任凤学, 许振业, 王韶屏, 柳景华*.急性冠状动脉综合征患者血清血栓调节蛋白和脂蛋白相关磷脂酶A2水平变化及临床意义.心肺血管病杂志.2020.39(02).134-138.核心期刊 |
6. Zhao Yejing#, Peng Hongyu, Li Xiaonan, Liu Jinghua*..The impact of dissection and re-entry versus wire escalation techniques on long-term clinical outcomes in patients with chronic total occlusion lesions following percutaneous coronary intervention: An updated meta-analysis..Cardiology journal.2020.2(27).-.SCI |
7. Yejing Zhao#, Hongyu Peng, Shaoping Wang, Jinghua Liu*. .Clinical analysis of acute coronary syndrome patients with Qi-blood syndromes: establishment of a diagnostic prediction model for syndrome differentiation. .Annals of Palliative Medicine.2020.9(4).2096-2110.SCI |
8. 郭云飞#, 柳景华*.冠状动脉慢性完全闭塞合并分叉病变介入治疗.心血管病进展.2020.41(01).7-10.核心期刊 |
9. 柳景华.急性ST段抬高型心肌梗死合并心源性休克患者非梗死相关血管慢性完全闭塞病变治疗对预后的影响.中国实用内科杂志 .2019.39(09).786-788.核心期刊 |
10. Ze Zheng#, Zi chao Cheng , Shao ping Wang, Shi ying Li, Jian Wang, Hong yu Peng, Zheng Wu, Wen zheng Li, Yun Lv, Jia yu Tian, Shu juan Cheng, and Jing hua Liu*..Predictors for New Native-Vessel Occlusion in Patients with Prior Coronary Bypass Surgery: A Single-Center Retrospective Research..Cardiology Research and Practice.2019.1-8.1-8.SCI |
11. Yuchen Shi#, Shaoping Wang, Hongyu Peng, Yuan Lv, Wenzheng Li, Shujuan Cheng, Jinghua Liu*.Fibroblast Growth Factor 21 Attenuates Vascular Calcification by Alleviating Endoplasmic Reticulum Stress Mediated Apoptosis in Rats..International journal of biological sciences.2019.15(1).138-147.SCI |
12. Tao Zhang#, Gong Su, Shu-hua Mi, Hong-xia Yang, Wei Xin, Wen-long Dai and Jing-hua Liu*..Association Between Blood Glucose Variability and the Characteristics of Vulnerable Plaque in Elderly Non-ST Segment Elevation Acute Coronary Syndrome Patients..Int Heart J.2019.60(3).569-576.SCI |
13. 史雨晨#,柳景华*.成纤维细胞生长因子21与急性冠状动脉综合征关系的研究进展.中国介入心脏病学杂志.2019.27(1).52-54.核心期刊 |
14. 马彩云#, 刘祎秀, 任凤学, 许振业, 王韶屏, 柳景华*.冠心病合并糖尿病患者血清炎症因子水平变化及其临床意义.心肺血管病杂志.2019.38(04).330-333.核心期刊 |
15. Yejing Zhao#, Hongyu Peng, Xiaonan Li, Yujun Qin, Fangying Cao, Ding Peng and Jinghua Liu*..Dual antiplatelet therapy after coronary artery bypass surgery:is there an increase in bleeding risk? A meta-analysis.Interactive CardioVascular and Thoracic Surgery.2018.26.573-582.SCI |
16. CaiYun Ma#, ZhenYe Xu, ShaoPing Wang, HongYu Peng, Fang Liu, JingHua Liu*, FengXue Ren. .Chang of Inflammatory Factors in patients with acute coronary syndrome..Chin Med J.2018.131(12).1444-1449.SCI |
17. 赵烨婧#, 彭红玉, 秦宇君, 曹芳英, 王平, 柳景华*..经皮冠状动脉介入治疗术后不同剂量依诺肝素联合替格瑞洛对复杂冠状动脉病变的非ST段抬高型急性冠状动脉综合征患者临床事件的影响.中国介入心脏病学杂志.2018.26(3).129-137.核心期刊 |
18. 彭丁#,柳景华*.冠心病心力衰竭患者血运重建术后心脏性猝死的危险因素评估——CRISIS临床研究.中国介入心脏病学杂志.2018.26(6).301-305.核心期刊 |
19. 史雨晨*,柳景华#.成纤维细胞生长因子21与急性心肌梗死的研究进展.中华老年心脑血管病杂志.2018.20(11).1213-1214.核心期刊 |
20. Xiaoxiao Liu#, Fangying Cao, Shuang Liu, Yuhong Mi, Jinghua Liu**.BMP2/Smad signaling pathway is involved in the inhibition function of fibroblast growth factor 21 on vascular calcification.Biochem. Biophys. Res. Commun.2018.503(2).930-937.SCI |
21. Shi YC#, Lu WW, Hou YL, Fu K, Gan F, Cheng SJ, Wang SP, Qi YF, Liu JH*.Protection Effect of Exogenous Fibroblast Growth Factor 21 on the Kidney Injury in Vascular Calcification Rats.Chin Med J.2018.131(5).532-538.SCI |
22. Shi Y#, Lu W, Hou Y, Fu K, Gan F, Liu J*.Fibroblast growth factor 21 ameliorates vascular calcification by inhibiting osteogenic transition in vitamin D3 plus nicotine-treated rats.Biochem. Biophys. Res. Commun.2018.495(4).2448-2455.SCI |
23. 吴铮#, 郑泽 ,柳景华*.冠状动脉旋磨术联合药物洗脱支架治疗 冠状动脉重度钙化病变的效果与安全性.中国综合临床.2018.34(1).15-20.核心期刊 |
24. 郑泽#,柳景华*.低转速和高转速旋磨治疗冠状动脉钙化病变的对比研究。.中国介入心脏病学杂志.2018.26(8).425-429.核心期刊 |
25. Huiping Zhang#,Jinghua Liu*.Effect of Chronic Total Occlusion Percutaneous Coronary Intervention on Clinical Outcomes in Elderly Patients.The American Journal of The Medical Sciences.2018.355(2).174-182.SCI |
26. 许振业#, 柳景华*, 刘建勋, 王韶屏, 任钧国, 程姝娟, 马彩云, 马芹, 吕媛, 吴铮, 彭红玉, 赵烨婧.急性冠脉综合征同病异证与TM、ICAM-1、Lp-PLA2水平的相关性研究.中国中西医结合杂志.2018.38(05).530-533.核心期刊 |
27. 彭丁#,柳景华*.红细胞分布宽度与血运重建术后缺血性心力衰竭患者预后的关系--CRISIS临床研究.心肺血管病杂志.2018.37(5).388-392.核心期刊 |
28. 史雨晨#,柳景华*.他汀类药物与冠状动脉钙化关系的研究进展.中国动脉硬化杂志.2018.26(12).1212-1215.核心期刊 |
29. Peng D#, Liu JH*.Improvement of LVEF in patients with HFrEF with coronary heart disease after revascularization—A real-world study.J Interv Cardiol.2018.31(6).1-6.SCI |
30. 郑斌#, 刘睿方, 刘然, 柳景华*.高尿酸血症在高血压患者肾动脉病变进展中的意义.中国医药.2018.7(13).977-981.核心期刊 |
31. 彭丁#,柳景华*..高尿酸血症与血运重建术后冠心病心力衰竭患者预后的关系.中华医学杂志.2018.98(17).1337-1341.核心期刊 |
32. 吴铮#, 吕昀, 王平, 李文铮, 柳景华*.急性非ST段抬高型心肌梗死患者血清hs-CRP、CK-MB、cTnI、NT-pro BNP的表达及临床意义.疑难病杂志.2018.17(12).1297-1300.核心期刊 |
33. 史雨晨#,吴丹妮,彭丁,柳景华*.局限性心脏压塞的超声特征.中国介入心脏病学杂志.2017.25(01).45-47.核心期刊 |
34. Hu S# , Cao S , Liu J *. .Role of angiopoietin-2 in the cardioprotective effect of fibroblast growth factor 21 on ischemia/reperfusion-induced injury in H9c2 cardiomyocytes..Experimental & Therapeutic Medicine.2017.14(1).771-779.SCI |
35. 史雨晨#,吴丹妮,彭丁,柳景华*.论局限性心脏压塞的症状和体征及治疗方式.中华老年心脑血管病杂志.2017.19(04).426-427.核心期刊 |
36. Fangying Cao#, Shaoping Wang, Xiangrong Cao, Xiaoxiao Liu, Kun Fu, Peng Hao and Jinghua Liu*.Fibroblast growth factor 21 attenuates calcification of vascular smooth muscle cells in vitro .Journal of Pharmacy and Pharmacology.2017.69(12).1802-1816.SCI |
37. 郑泽#,柳景华*.冠状动脉旁路移植术后慢性完全闭塞病变的介入治疗现状.心肺血管病杂志.2017.36(10).872-874 .核心期刊 |
38. MA Cai-yun#, LIU Jing-hua*, LIU Jian-xun, SHI Da-zhuo, XU Zhen-ye, WANG Shao-ping, JIA Min, ZHAO FU-hai, JIANG YUE-rong, MA Qin, PENG Hong-yu, LU Yua, ZHENG Ze, and REN Feng-xue.Relationship between Two Blood Stasis Syndromes and Infl ammatory Factors in Patients with Acute Coronary Syndrome..Chin J Integr Med.2017.23(11).845-849.SCI |
39. 许振业#, 柳景华*, 刘建勋, 王韶屏, 任钧国, 程姝娟, 马彩云, 马芹, 吕媛, 吴铮, 彭红玉, 赵烨婧.急性冠状动脉综合征同病异证与一氧化氮、内皮素-1、血管紧张素转化酶水平相关性的研究.心肺血管病杂志.2017.36(10).800-803.核心期刊 |
40. 史雨晨#,柳景华*.血管钙化大鼠模型肾脏β-Klotho及成纤维细胞生长因子受体1表达研究.中国循环杂志.2017.32(05).507-510.核心期刊 |
41. 赵烨婧#,柳景华*.替格瑞洛与其他P2Y12受体拮抗剂相互转换应用的研究进展.中华医学杂志.2017.97(11).878-880.核心期刊 |
42. 史雨晨#,柳景华*.血管钙化大鼠肾脏损伤及其FGF21的表达.中华医学杂志.2016.96(46).3741-3744.核心期刊 |
43. 赵烨婧#,柳景华*.二尖瓣反流:预测心脏再同步治疗效果的新指标 .中华医学杂志.2016.96(23).1803-1805.核心期刊 |
44. 曹芳英#,柳景华*.左心室多位点起搏心脏再同步化治疗研究进展.中国介入心脏病学杂志 .2016.24(02).110-113 .核心期刊 |
45. 马彩云#,柳景华*,任凤学,董鹏,彭红玉.冠状动脉多聚合物生物可吸收支架的研究.中华老年心脑血管病杂志.2016.18(07).759-761.核心期刊 |
46. 许振业#,柳景华*,王韶屏,马彩云.经皮冠状动脉介入治疗对内皮功能影响的研究进展.心肺血管病杂志.2016.35(07).584-587.核心期刊 |
47. 马彩云#,任凤学, 王韶屏, 马芹, 柳景华*.冠心病与血管内皮细胞标志物关系的研究.中国介入心脏病学杂志.2016.24(02).104-106.核心期刊 |
48. 史雨晨#,柳景华*.成纤维细胞生长因子受体1在大鼠各组织中的表达.新乡医学院学报.2016.33(11).945-949.核心期刊 |
49. 马彩云#,柳景华,王韶屏,吕媛,许振业*.内皮功能障碍与冠心病的研究.心肺血管病杂志 .2016.35(06).482-484 .核心期刊 |
50. 史雨晨#,吴丹妮,彭丁,柳景华*.局限性心脏压塞的发病机制及临床特征.心肺血管病杂志.2016.35(12).999-1001.核心期刊 |
51. 彭红玉#,柳景华*,吕志阳,郑旭伟,李芳.血清内脂素水平与慢性稳定性冠心病的关系.中国动脉硬化杂志.2016.24(01).67-71.核心期刊 |
52. Hujun Wang#, Jinghua Liu*, Xu Zheng, Xiaohui Rong, Xuwei Zheng, Hongyu Peng, Zhanghua Silber-Li, Mujun Li & Liyu Li. .Three-dimensional virtual surgery models for percutaneous coronary intervention (PCI) optimization. .SCIENTIFIC REPORTS.2015.04 June .1-11 .SCI |
53. Qin Ma#, Bin Zheng, Kang Meng, Qiang Yong, Yihua He, Jian Wang, Shiying Li, Donghui Zhao, Zhenye Xu, Peng Hao, Hua Chen, Kun Fu, Ruixi Liu, Shujuan Cheng, Jinghua Liu*..A simple score for predicting renal artery stenosis in patients with ischemic heart disease..Int J Clin Exp Med.2015.8(3).4302-4310.SCI |
54. 彭红玉#,柳景华*,吕志阳,郑旭伟,章新新.经胸超声心动图测量心外膜脂肪厚度与冠心病的相关性研究.临床心血管病杂志.2015.31(12).1279-1282.核心期刊 |
55. 彭红玉#,柳景华*,吕志阳,郑旭伟,李芳.血管造影诊断成人冠状动脉起源异常的单中心经验.临床心血管病杂志 .2015.31(09).936-940.核心期刊 |
56. Qian Fan#, Lifen Chen, Shujuan Cheng, Fang Li, Wayne Bond Lau, Le Feng Wang, and Jing Hua Liu*.Aging Aggravates Nitrate-Mediated ROS/RNS Changes. Oxidative Medicine and Cellular Longevity.Oxid Med Cell Longev.2014.2014.376515.SCI |
57. Ming Zhang#, Min Yang, Li-ping Liu, Wayne Bond Lau, Hai Gao, Man-kun Xin, Li-Xiao Su, Jian Wang, Shu-Juan Cheng, Qian Fan, and Jing-Hua Liu*.BMP-2 Overexpression Augments Vascular Smooth Muscle Cell Motility by Upregulating Myosin Va via Erk Signaling.Oxidative Medicine and Cellular Longevity.2014.2014.PMID- 24790701.SCI |
58. Wang guo-zhong,Liu jing-hua*,lv shu-zheng,Lv yun.Ultrasonic destruction of albumin microbubbles enhances gene transfection and expression in cardiac myocytes.Chin med J.2011.124(5).341-347.SCI |
59. Lv Yun,LIU Jing-hua* ,ZHANG Li-ke ,DU Jie,ZENG Xiang-jun ,HAO Gang,HUANG Ji,ZHAO Dong-hui,WANG Guo-zhong,ZHANG Ying-chuan .Fibroblast growth factor 21 as a possible endogenous factor inhibits apoptosis in cardiac endothelial cells.Chin med J.2010.123(23).3417-3421.SCI |
60. Liu J,Lou Y, Huang Y, Liu J, Wang Z, Liu Y, Li Z, Li Y, Xie Y, Wen S..A46G and C79G polymorphisms in the β2-adrenergic receptor gene (ADRB2) and essential hypertension risk: a meta-analysis.Hypertens Res.2010.33(11).1114-1123.SCI |
61. 汪国忠,柳景华*,吕树铮.超声破裂载基因微泡增强心肌细胞受磷蛋白反义RNA转染.中华超声影像学杂志.2010.19(10).897-900.核心期刊 |
62. 柳景华*,丁燕生,孙璐.多黏菌素B阻断蛋白激酶C活化后的缺血心肌保护作用.中国介入心脏病学杂志.2008.16(3).167-171.核心期刊 |
63. 卢春山,柳景华*,马长生.外科射频消融术与经导管消融术治疗瓣膜性房颤的疗效对比.中华胸心血管外科杂志,24(5).2008.24(5).320-322.核心期刊 |
64. 柳景华.非ST段抬高急性冠状动脉综合征早期治疗策略的再认识:FRISC II 5年结果.临床荟萃.2007.22(9).609-611.核心期刊 |
65. 顾菲菲,柳景华*.静脉应用不同负荷剂量胺碘酮转复心房颤动的分析.医师进修杂志, 28(10A).2005.28(10).48-49.核心期刊 |
66. 王学英,柳景华*.洋地黄治疗心力衰竭再认识.中国心血管病研究杂志, 3(6).2005.3(8).580-582.核心期刊 |